Recruiting Advanced Solid Tumors Studies in Leuven
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors....
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
This pan-tumor trial is designed as a signal-seeking trial to assess efficacy and safety of raludotatug deruxtecan (R-DXd) monotherapy in locally advanced or metastatic solid tumors with various cadhe...
About Advanced Solid Tumors Clinical Trials in Leuven
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 2 advanced solid tumors clinical trials recruiting participants in Leuven, VLAAMS%20BRABANT. These studies are seeking a combined 670 participants. Research is being sponsored by Daiichi Sankyo. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Leuven — FAQ
Are there advanced solid tumors clinical trials in Leuven?
Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Leuven, VLAAMS%20BRABANT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Leuven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Leuven research site will contact you about next steps.
Are clinical trials in Leuven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Leuven studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 2 active trials in Leuven are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov